Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

Standard Surfactants

₹59 -0.3 | 0.4%

Market Cap ₹49 Cr.

Stock P/E 36.1

P/B 1.8

Current Price ₹59

Book Value ₹ 33.3

Face Value 10

52W High ₹92.4

Dividend Yield 0%

52W Low ₹ 51

Standard Surfactants Research see more...

Overview Inc. Year: 1989Industry: Detergents & Soaps

Standard Surfactants Ltd manufactures and sells detergents and organic chemical compounds in India. The company operates in 2 segments, Chemical and Surface Active, and Others. It also operates as a consignment stockiest of excessive and linear low-density polyethylene, poly propylene, paraffin wax, and other petro and petroleum products. The enterprise was founded in 1989 and is based in Kanpur, India.

Read More..

Standard Surfactants Share Price

New

| |

Volume
Price

Quarterly Price

Show Value Show %

Standard Surfactants Quarterly Results

#(Fig in Cr.) Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Jun 2023 Sep 2023 Dec 2023
Net Sales 33 32 29 30 43 42 34 30 32 32
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 33 33 29 30 43 42 34 30 32 33
Total Expenditure 31 32 28 29 42 41 33 29 30 32
Operating Profit 2 1 1 1 1 1 0 1 1 0
Interest 0 -0 0 0 0 0 0 0 1 -0
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 2 1 1 0 1 1 0 0 0 0
Provision for Tax 0 0 0 0 0 0 0 -0 0 -0
Profit After Tax 1 1 0 0 1 0 0 0 0 0
Adjustments 0 -0 0 -0 0 -0 0 0 -0 0
Profit After Adjustments 1 1 0 0 1 0 0 0 0 0
Adjusted Earnings Per Share 1.6 1 0.6 0.3 0.9 0.6 0.2 0.5 0.3 0.6

Standard Surfactants Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 52 53 53 44 55 87 117 83 92 125 152 128
Other Income 0 0 0 1 1 0 0 0 0 1 1 0
Total Income 52 53 54 45 56 87 118 83 93 125 153 129
Total Expenditure 49 50 51 42 53 85 115 81 88 121 150 124
Operating Profit 3 3 3 3 3 3 3 2 4 5 4 2
Interest 2 2 2 1 2 1 1 1 1 1 1 1
Depreciation 1 1 1 1 1 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 0 1 1 1 1 1 1 1 3 3 2 0
Provision for Tax 0 0 0 0 0 0 0 -0 1 1 1 0
Profit After Tax 0 0 0 0 0 1 1 1 2 2 2 0
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 0 0 0 0 0 1 1 1 2 2 2 0
Adjusted Earnings Per Share 0.4 0.6 0.6 0.6 0.6 1.4 1.2 1.3 3.1 3.5 2 1.6

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 22% 22% 12% 11%
Operating Profit CAGR -20% 26% 6% 3%
PAT CAGR 0% 26% 15% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -7% 20% 31% NA%
ROE Average 7% 11% 9% 6%
ROCE Average 7% 9% 8% 9%

Standard Surfactants Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 14 15 12 13 13 14 15 15 18 21 24
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 4 2 0 0 1 1 1 3 6 7 6
Other Non-Current Liabilities 0 0 1 1 1 1 1 1 1 1 1
Total Current Liabilities 11 13 14 15 17 23 25 23 23 24 33
Total Liabilities 30 29 28 29 32 38 41 42 48 52 64
Fixed Assets 11 11 8 8 7 7 6 6 6 6 6
Other Non-Current Assets 1 0 1 1 3 2 1 1 3 2 4
Total Current Assets 18 18 19 20 22 30 34 34 39 44 55
Total Assets 30 29 28 29 32 38 41 42 48 52 64

Standard Surfactants Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 1 1 0 1 1 1 1 3 1 1 0
Cash Flow from Operating Activities 2 4 5 3 -0 -1 2 4 -4 1 0
Cash Flow from Investing Activities -1 -1 -0 0 1 1 -0 -6 2 -0 -4
Cash Flow from Financing Activities -1 -3 -4 -3 -1 1 -0 1 1 -2 6
Net Cash Inflow / Outflow -0 -0 1 0 -0 0 2 -2 -0 -1 1
Closing Cash & Cash Equivalent 1 1 1 1 1 1 3 1 1 0 1

Standard Surfactants Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 0.44 0.57 0.65 0.61 0.61 1.35 1.17 1.26 3.06 3.46 2.04
CEPS(Rs) 1.35 1.53 1.85 1.51 1.31 2.02 1.81 1.86 3.64 4.05 2.61
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 19.98 20.55 17.03 17.65 17.9 19.25 20.42 21.63 24.72 28.15 31.17
Core EBITDA Margin(%) 3.54 3.93 4.04 3.62 3.23 2.79 2.3 2.39 4.42 3.19 1.86
EBIT Margin(%) 3.01 3.27 3.22 3.88 3.64 2.48 2.16 2.28 4.4 3.33 2.16
Pre Tax Margin(%) 0.55 0.81 0.97 1.17 1.04 1.11 1.06 1.05 3.37 2.57 1.37
PAT Margin (%) 0.44 0.58 0.65 0.79 0.69 1.08 0.71 1.09 2.35 1.97 1.02
Cash Profit Margin (%) 1.35 1.56 1.86 1.95 1.5 1.61 1.1 1.6 2.8 2.31 1.31
ROA(%) 1.06 1.37 1.61 1.54 1.43 2.73 2.09 2.17 4.87 4.93 2.68
ROE(%) 2.24 2.81 3.44 3.53 3.42 7.28 5.92 6.01 13.19 13.08 7.11
ROCE(%) 8.28 8.95 10.14 10.01 8.97 7.53 8.03 5.6 10.91 10.17 7.14
Receivable days 52.11 50.88 48.92 63.06 69.42 71.8 65.3 84.46 72.38 64.34 61.99
Inventory Days 20.25 18.99 15.34 20.8 17.75 13.82 14.03 17.67 22.09 23.07 19.1
Payable days 14.18 14.89 15.98 23.51 12.7 13.72 20.44 26.88 19.08 18.63 23.36
PER(x) 0 0 0 0 0 0 17.86 8.54 9.22 17.12 25.73
Price/Book(x) 0 0 0 0 0 0 1.03 0.5 1.14 2.1 1.69
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.35 0.31 0.26 0.35 0.39 0.25 0.25 0.22 0.39 0.46 0.36
EV/Core EBITDA(x) 6.56 5.57 4.4 5.58 7.65 8.12 9.95 8.62 7.97 12.62 14.65
Net Sales Growth(%) 14.57 1.63 1.63 -17.31 24.45 58.57 34.62 -29.55 11.83 34.84 22.38
EBIT Growth(%) 10.04 6.96 -0.15 -6 5.72 -2.73 14.96 -25.73 116.02 2.18 -20.57
PAT Growth(%) 20.2 28.72 13.61 -5.51 -0.69 122.72 -13.23 7.66 142.02 13.09 -36.63
EPS Growth(%) 20.19 28.73 13.61 -5.51 -0.69 122.73 -13.23 7.66 142.02 13.09 -40.93
Debt/Equity(x) 0.84 0.7 0.66 0.81 1.18 1.24 1.23 1.26 1.26 1.04 1.09
Current Ratio(x) 1.56 1.44 1.33 1.39 1.29 1.34 1.34 1.5 1.69 1.84 1.64
Quick Ratio(x) 1.2 1.18 1.14 1.15 1.14 1.15 1.17 1.36 1.35 1.52 1.39
Interest Cover(x) 1.22 1.33 1.43 1.43 1.4 1.82 1.96 1.85 4.26 4.38 2.74
Total Debt/Mcap(x) 0 0 0 0 0 0 1.19 2.52 1.09 0.49 0.64

Standard Surfactants Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 57.26 57.26 57.26 57.26 57.26 60.14 63.02 63.02 63.02 62.89
FII 0 0 0 0 0 0 0 0 0 0
DII 0.12 0.12 0.12 0.12 0.12 0.11 0.11 0.11 0.11 0.11
Public 42.62 42.62 42.62 42.62 42.62 39.74 36.87 36.87 36.88 37
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company has reduced debt.

Cons

  • Company has a low return on equity of 11% over the last 3 years.
  • Debtor days have increased from 18.63 to 23.36days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Standard Surfactants News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....